A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00233571
Recruitment Status : Completed
First Posted : October 6, 2005
Last Update Posted : November 22, 2011
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2006
  Study Completion Date : June 2006